Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Carcinoma
|
103 | 0.683 | 0.360 | 3 | 41224610 | missense variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 2001 | 2001 | ||||||
Endometrial Carcinoma
|
326 | 0.683 | 0.360 | 3 | 41224610 | missense variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 2001 | 2001 | ||||||
Supratentorial Embryonal Tumor, Not Otherwise Specified
|
4 | 0.683 | 0.360 | 3 | 41224610 | missense variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 2001 | 2001 | ||||||
Stromal Neoplasm
|
1 | 0.683 | 0.360 | 3 | 41224610 | missense variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
Parathyroid Adenoma
|
12 | 0.683 | 0.360 | 3 | 41224610 | missense variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||
Brain Neoplasms
|
204 | 0.683 | 0.360 | 3 | 41224610 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 1 | 2014 | 2014 | ||||||
Endometrial Neoplasms
|
32 | 0.683 | 0.360 | 3 | 41224610 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 1 | 2014 | 2014 | ||||||
ovarian neoplasm
|
757 | 0.683 | 0.360 | 3 | 41224610 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 1 | 2014 | 2014 | ||||||
Parathyroid Neoplasms
|
9 | 0.683 | 0.360 | 3 | 41224610 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 1 | 2014 | 2014 | ||||||
Colorectal Carcinoma
|
1962 | 0.683 | 0.360 | 3 | 41224610 | missense variant | C/A;G;T | snv | 0.800 | 1.000 | 10 | 2006 | 2015 | ||||||
Medulloblastoma
|
115 | 0.683 | 0.360 | 3 | 41224610 | missense variant | C/A;G;T | snv | 0.810 | 1.000 | 5 | 2000 | 2016 | ||||||
Adenocarcinoma of lung (disorder)
|
563 | 0.683 | 0.360 | 3 | 41224610 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Adenocarcinoma of pancreas
|
138 | 0.683 | 0.360 | 3 | 41224610 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Adenocarcinoma of prostate
|
108 | 0.683 | 0.360 | 3 | 41224610 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Colorectal Neoplasms
|
609 | 0.683 | 0.360 | 3 | 41224610 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Cutaneous Melanoma
|
248 | 0.683 | 0.360 | 3 | 41224610 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Esophageal carcinoma
|
272 | 0.683 | 0.360 | 3 | 41224610 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Gastric Adenocarcinoma
|
235 | 0.683 | 0.360 | 3 | 41224610 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Liver carcinoma
|
942 | 0.683 | 0.360 | 3 | 41224610 | missense variant | C/A;G;T | snv | 0.800 | 1.000 | 1 | 2016 | 2016 | ||||||
Malignant Uterine Corpus Neoplasm
|
152 | 0.683 | 0.360 | 3 | 41224610 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Transitional cell carcinoma of bladder
|
158 | 0.683 | 0.360 | 3 | 41224610 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Pilomatrixoma
|
14 | 0.683 | 0.360 | 3 | 41224610 | missense variant | C/A;G;T | snv | 0.800 | 1.000 | 6 | 1999 | 2017 | ||||||
Calcifying Odontogenic Cyst
|
1 | 0.683 | 0.360 | 3 | 41224610 | missense variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Neoplasms, Intracranial
|
4 | 0.683 | 0.360 | 3 | 41224610 | missense variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Neoplasms
|
1644 | 0.683 | 0.360 | 3 | 41224610 | missense variant | C/A;G;T | snv | 0.030 | 1.000 | 3 | 2011 | 2019 |